Market view
palbociclib · Crystal
0 marketed package NDCs · 1 maker active in the last 30 days
Not counted: 1 bulk-ingredient, export-only or further-processing listing.
ⓘ How this was built
- FDA NDC Directory (openFDA), read daily — package listings, marketing category, labeler
- DailyMed SPL establishment roles + name patterns → derived.labeler_kinds (repackager classification)
Marketed package NDCs are listings for this exact FDA generic-name string (and dosage form, when one is selected) that are in the current directory file and are finished products — bulk ingredients, export-only and further-processing listings are excluded and counted separately. Makers are distinct labeler names seen in the last 30 days minus classified repackagers/relabelers; a listing is not proof of shipping volume. To check: search the generic name in FDA's NDC Directory and count labelers.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for palbociclib, newest first — price moves, shortages, recalls, and labelers entering or leaving. Detected by comparing each day’s federal data against what we already held.
ⓘ How this was built
- DrugDashboards change feed — daily diffs of the NDC Directory, NADAC, FDA shortages and enforcement reports, Part D formularies
Events whose NDC belongs to a product with this generic-name string, dated by the day the change was detected (the file's own effective date is shown on price rows). Generic NADAC is a 3-month moving average since December 2024, so most price moves here are small and lag the market.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- PalbociclibAug 12, 2026Labeler exitedShanghai Huilun Jiangsu Pharmaceutical Co., Ltd. · palbociclib
Same drug class
Other molecules FDA puts in Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
ⓘ How this was built
- FDA NDC Directory pharmacologic class (EPC) per product
- FDA drug shortages (openFDA)
- FDA NDC Directory labelers + derived.labeler_kinds
Peers share this drug's most common Established Pharmacologic Class. 'In shortage' means an FDA Current row whose NDC belongs to that molecule or whose listing name normalizes to it (any presentation). Maker counts are labelers active in the last 30 days minus repackagers, across all forms.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Common questions
- Is Palbociclib in shortage right now?
- No. FDA's shortage list has no current entry for Palbociclib under this name or its presentations. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Palbociclib?
- 17 companies have listed Palbociclib in the FDA NDC Directory in the last 30 days. A listing is not proof of volume; the products below show every listed package.
ⓘ How this was built
- FDA drug shortages (openFDA)
- FDA NDC Directory + derived.labeler_kinds
- CMS NADAC weekly file
Shortage: any Current FDA row whose package NDC belongs to this generic-name string or whose listing name normalizes to the same molecule; the presentations named are those rows. Makers: distinct labelers listing this string in the last 30 days, repackagers excluded. Cost: the median of each NDC's most recent NADAC within 6 months, restricted to the market's most common billing unit and to the generic cohort when one exists.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
All marketed products
0 marketed NDCs, every one listed. NADAC prices show the file date; prices older than 6 months are greyed.
ⓘ How this was built
- FDA NDC Directory (openFDA) — products, packages, labelers, marketing category, TE code (application-level)
- CMS NADAC — each NDC's latest price
- DrugDashboards fragility v1 score
Finished products currently in the NDC Directory under this generic-name string (bulk, export-only and further-processing listings excluded). 'Widely marketed' marks the four form/strength/package combinations with the most NADAC-priced NDCs — a proxy for retail availability, not dispensing volume. Labeler counts in the tree include repackagers, marked in the roster on each drug page.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No finished products are currently listed under this name.